Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Equity Ratio: 2024-2025

Historic Equity Ratio for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to 0.37.

  • Kura Oncology's Equity Ratio fell 57.80% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 57.80%. This contributed to the annual value of 0.54 for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Equity Ratio of 0.37 as of Q3 2025, which was down 16.56% from 0.45 recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Equity Ratio ranged from a high of 0.91 in Q1 2024 and a low of 0.37 during Q3 2025.
  • Moreover, its 2-year median value for Equity Ratio was 0.54 (2024), whereas its average is 0.65.
  • Data for Kura Oncology's Equity Ratio shows a maximum YoY slumped of 57.80% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Equity Ratio (Quarterly) stood at 0.54 in 2024, then tumbled by 57.80% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.45 for Q2 2025, and 0.49 during Q1 2025.